2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA
Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
Corporate Presentation July 2025
Shareholder votes
Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
Annual Report to Security Holders
Reports First Quarter 2025 Financial Results and Provides Corporate Update
Q2
Q1
FY 2023
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
S-8 POS